Neogen Corp NEOG

Neogen (NASDAQ:NEOG) shareholders approved all five proposals presented at the company’s 2026 annual meeting, including the election of three directors, advisory approval of executive compensation, and amendments to the company’s equity incentive and employee stock purchase plans. Chair of the Boar

Shares of life sciences company Neogen (NASDAQ:NEOG) fell 5.4% in the afternoon session after the U.S. Food and Drug Administration issued warning letters to the company following laboratory tests that uncovered fungal contamination in its veterinary product HYCOAT.

“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.

Neogen has delivered a sharp share price swing in a short span, and the recent run has investors asking whether the current valuation is still grounded in its sales profile. With the stock now reflecting a very different market view than a few years ago, the key issue is how that view lines up with what the business actually generates in revenue. The stock has returned 153.2% over the past year, which puts real pressure on the question of whether today’s price can be explained by its sales...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 38.9% gain over the past six months, beating the S&P 500 by 20.9 percentage points.

LANSING, Mich., September 15, 2026--Neogen® Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release after the closing of the market on October 6, 2026. Executives from the company will host a webcast and conference call beginning at 4:30 p.m. Eastern time, to discuss the financial results.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Over the past six months, Neogen has been a great trade, beating the S&P 500 by 8.3%. Its stock price has climbed to $11.93, representing a healthy 21% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.